Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists

European Journal of Neuroscience

Volumn 10, Issue 11, 1998, Pages 3546-3555

  Tremblay, Pierre Olivier ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Antagonists; Atypical neuroleptic; Clozapine; Dopamine; Rat; Typical neuroleptic

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CLOZAPINE; HALOPERIDOL; SEROTONIN AGONIST; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; FOREBRAIN; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMPHETAMINES; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HALOPERIDOL; MALE; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS;

EID: 0032466201     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1998.00372.x     Document Type: Article

References (1)

1. Arranz, M., Collier, D., Sodhi, M., Ball, D., Roberts, G., Price, J., Sham, P. & Kerwin, R. (1995) Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet, 346, 281-282.